The Benchmark Company Announces Upcoming Discovery One on One Virtual Investor Conference
11 nov. 2020 10h00 HE
|
The Benchmark Company
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Discovery One on One Virtual Investor Conference on Wednesday, November 18th, 2020. The...
The Benchmark Company Announces Upcoming Technology One on One Virtual Investor Conference
05 nov. 2020 10h21 HE
|
The Benchmark Company
NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual One on One Technology Investor Conference on Thursday, November 12th, 2020. The...
The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1x1 Investor Conference
11 juin 2020 16h34 HE
|
The Benchmark Company
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual 1x1 “Healthcare House Call” Investor Conference June 15-16th. The conference features...
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
28 mai 2020 10h02 HE
|
The Benchmark Company
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...
The Benchmark Company Announces Closing of $8 Million Registered Direct Offering for Cinedigm Corp.
26 mai 2020 18h37 HE
|
The Benchmark Company
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on May 22nd of a Registered Direct Offering of 10,666,666 shares of common stock of Cinedigm Corp. (NASDAQ:...
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
17 mars 2020 12h29 HE
|
The Benchmark Company
NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 7,500,000 shares of...
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
26 févr. 2020 09h00 HE
|
The Benchmark Company, Llc
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
13 févr. 2020 15h51 HE
|
The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...
The Benchmark Company Adds Kevin Sterling to Industrial Research Team
12 févr. 2020 13h49 HE
|
The Benchmark Company, Llc
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the addition of Kevin Sterling to its rapidly growing equity research team. Kevin will cover the...
The Benchmark Company Adds Industrial Research Team to Its Growing Platform
09 janv. 2020 09h00 HE
|
The Benchmark Company, Llc
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced a significant expansion of its equity research platform, which includes the addition of four senior research...